1
|
Shen Z, Tan Z, Ge L, Wang Y, Xing X, Sang W, Cai G. The global burden of lymphoma: estimates from the Global Burden of Disease 2019 study. Public Health 2024; 226:199-206. [PMID: 38086101 DOI: 10.1016/j.puhe.2023.11.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Revised: 10/18/2023] [Accepted: 11/09/2023] [Indexed: 01/15/2024]
Abstract
OBJECTIVES The aim of this study was to describe the global trends in the burden of lymphoma from 1990 to 2019. STUDY DESIGN The data used in this study were from the Global Burden of Disease 2019 study. METHODS This study described the age-standardised rates of incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs) of lymphoma (non-Hodgkin and Hodgkin's lymphoma, NHL and HL, respectively) annually from 1990 to 2019, stratified by sociodemographic index (SDI) and 21 world regions. The estimated annual percentage changes in these indexes were calculated. RESULTS In 2019, the age-standardised rates of HL per 100,000 population were lower than those of NHL in terms of incidence (1.1 vs 6.7 per 100,000 person-years, respectively) and prevalence (0.3 vs 5.7 per 100,000 person-years, respectively) but not mortality (21.6 vs 3.2 per 100,000 person-years, respectively). From 1999 to 2019, the global incidence of HL decreased and the incidence of NHL increased, and the prevalence of both HL and NHL increased, but the mortality rates decreased. When stratified by SDI, the incidence of HL decreased in all but middle-SDI regions, the mortality rate of HL decreased in all regions, and both the incidence and mortality rate of NHL increased in all but high-SDI regions. The prevalence of HL and NHL increased in all SDI regions, especially in middle-SDI regions. YLLs and DALYs of HL in all SDI regions and those of NHL in high-SDI regions decreased. YLDs slightly increased in middle- to high-SDI regions. CONCLUSIONS Lymphoma remains a major public health issue, and better prevention, precise identification, and promising treatments are vitally important.
Collapse
Affiliation(s)
- Z Shen
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, China
| | - Z Tan
- Research Center of Health Policy and Health Management, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China
| | - L Ge
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, China
| | - Y Wang
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, China
| | - X Xing
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, China
| | - W Sang
- Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou Jiangsu, 221006, China.
| | - G Cai
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, China; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, 7000, Australia.
| |
Collapse
|
2
|
Sun Q, Qi YK, Qi KM, Yan ZL, Cheng H, Chen W, Zhu F, Sang W, Li DP, Cao J, Shi M, Li ZY, Xu KL. [Observation of liver indexes in patients with relapsed/refractory multiple myeloma treated with CAR-T-cells based on BCMA]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:832-837. [PMID: 38049335 PMCID: PMC10694074 DOI: 10.3760/cma.j.issn.0253-2727.2023.10.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Received: 08/25/2023] [Indexed: 12/06/2023]
Abstract
Objective: To observe the characteristics of the evolution of liver indexes in patients with relapsed/refractory multiple myeloma (RRMM) treated with CAR-T-cells based on BCMA. Methods: Retrospective analysis was performed of patients with RRMM who received an infusion of anti-BCMA CAR-T-cells and anti-BCMA combined with anti-CD19 CAR-T-cells at our center between June 1, 2019, and February 28, 2023. Clinical data were collected to observe the characteristics of changes in liver indexes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and direct bilirubin (DBIL) in patients, and its relationship with cytokine-release syndrome (CRS) . Results: Ninety-two patients were included in the analysis, including 41 patients (44.6%) in the group receiving a single infusion of anti-BCMA CAR-T-cells, and 51 patients (55.4%) in the group receiving an infusion of anti-BCMA combined with anti-CD19 CAR-T-cells. After infusing CAR-T-cells, 31 patients (33.7%) experienced changes in liver indexes at or above grade 2, which included 20 patients (21.7%) with changes in one index, five patients (5.4%) with changes in two indexes, and six patients (6.5%) with changes in three or more indexes. The median time of peak values of ALT and AST were d17 and d14, respectively, and the median duration of exceeding grade 2 was 5.0 and 3.5 days, respectively. The median time of peak values of TBIL and DBIL was on d19 and d21, respectively, and the median duration of exceeding grade 2 was 4.0 days, respectively. The median time of onset of CRS was d8, and the peak time of fever was d9. The ALT, AST, and TBIL of patients with CRS were higher than those of patients without CRS (P=0.011, 0.002, and 0.015, respectively). CRS is an independent factor that affects ALT and TBIL levels (OR=19.668, 95% CI 18.959-20.173, P=0.001). The evolution of liver indexes can be reversed through anti-CRS and liver-protection treatments, and no patient died of liver injury. Conclusions: In BCMA-based CAR-T-cell therapy for RRMM, CRS is an important factor causing the evolution of liver indexes. The evolution of liver indexes after CAR-T-cell infusion is transient and reversible after treatment.
Collapse
Affiliation(s)
- Q Sun
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - Y K Qi
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - K M Qi
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - Z L Yan
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - H Cheng
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - W Chen
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - F Zhu
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - W Sang
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - D P Li
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - J Cao
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - M Shi
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - Z Y Li
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - K L Xu
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| |
Collapse
|
3
|
Wang XM, Zhou Y, Zhang JL, Zhou HY, Zhang Q, Sun Q, Li HJ, Xu LY, Yao SN, Yao ZH, Yan DM, Xu KL, Sang W. [Allogeneic hematopoietic stem cell transplantation combined with CD7 CAR-T for the treatment of T lymphoblastic lymphoma: a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:864-865. [PMID: 38049342 PMCID: PMC10694072 DOI: 10.3760/cma.j.issn.0253-2727.2023.10.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Indexed: 12/06/2023]
Affiliation(s)
- X M Wang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - Y Zhou
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - J L Zhang
- Department of Rehabilitation, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China
| | - H Y Zhou
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - Q Zhang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - Q Sun
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - H J Li
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - L Y Xu
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - S N Yao
- Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450000, China
| | - Z H Yao
- Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450000, China
| | - D M Yan
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - K L Xu
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - W Sang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| |
Collapse
|
4
|
Shen ZY, Chen XC, Shan HR, Jia T, Gu WY, Wang F, Teng QL, Wang L, Wang CL, Shi YY, Zhang H, Miao YQ, Zhu TG, Ji CY, Ye JJ, Zhang MZ, Zhang XD, Wang L, Xu KL, Sang W. [Analysis of prognostic factors of extranodal NK/T-cell lymphoma treated with pegaspargase/L-asparaginase: a multicenter retrospective study]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:642-648. [PMID: 37803837 PMCID: PMC10520233 DOI: 10.3760/cma.j.issn.0253-2727.2023.08.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Indexed: 10/08/2023]
Abstract
Objective: To explore the prognostic factors of extracellular NK/T cell lymphoma (ENKTL) treated with pegaspargase/L-asparaginase. Methods: The clinical data of 656 ENKTL patients diagnosed at 11 medical centers in the Huaihai Lymphoma Working Group from March 2014 to April 2021 were retrospectively analyzed. The patients were randomly divided into two groups: a training set (460 cases) and a validation set (196 cases) at 7∶3, and the prognostic factors of the patients were analyzed. A prognostic scoring system was established, and the predictive performance of different models was compared. Results: Patients' median age was 46 (34, 57) years, with 456 males (69.5% ) and 561 nasal involvement (85.5% ). 203 patients (30.9% ) received a chemotherapy regimen based on L-asparaginase combined with anthracyclines, and the 5-year overall survival rate of patients treated with P-GEMOX regimen (pegaspargase+gemcitabine+oxaliplatin) was better than those treated with SMILE regimen (methotrexate+dexamethasone+cyclophosphamide+L-asparaginase+etoposide) (85.9% vs 63.8% ; P=0.004). The results of multivariate analysis showed that gender, CA stage, the Eastern Cooperative Oncology Group performance status (ECOG PS) score, HGB, and EB virus DNA were independent influencing factors for the prognosis of ENKTL patients (P<0.05). In this study, the predictive performance of the prognostic factors is superior to the international prognostic index, Korean prognostic index, and prognostic index of natural killer lymphoma. Conclusion: Gender, CA stage, ECOG PS score, HGB, and EB virus DNA are prognostic factors for ENKTL patients treated with pegaspargase/L-asparaginase.
Collapse
Affiliation(s)
- Z Y Shen
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, China
| | - X C Chen
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - H R Shan
- Department of Hematology, Shuyang Hospital of Traditional Chinese Medicine, Suqian 223600, China
| | - T Jia
- Department of Hematology, the First People's Hospital of Lianyungang, Lianyungang 222002, China
| | - W Y Gu
- Department of Hematology, the First People's Hospital of Changzhou, Changzhou 213003, China
| | - F Wang
- Department of Hematology, the First People's Hospital of Changzhou, Changzhou 213003, China
| | - Q L Teng
- Department of Hematology, Taian Central Hospital, Taian 271000, China
| | - L Wang
- Department of Hematology, Taian Central Hospital, Taian 271000, China
| | - C L Wang
- Department of Hematology, Huai'an First People's Hospital, Huaian 223000, China
| | - Y Y Shi
- Department of Hematology, Huai'an First People's Hospital, Huaian 223000, China
| | - H Zhang
- Department of Hematology, the Affiliated Hospital of Jining Medical University, Jining 272000, China
| | - Y Q Miao
- Department of Hematology, Yancheng First People's Hospital, Yancheng 224001, China
| | - T G Zhu
- Department of Hematology, the General Hospital of Wanbei Coal-Electric Group, Suzhou 234000, China
| | - C Y Ji
- Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China
| | - J J Ye
- Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China
| | - M Z Zhang
- Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - X D Zhang
- Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - L Wang
- Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - K L Xu
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - W Sang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| |
Collapse
|
5
|
Lu K, Lang C, Zou X, Zang L, Sang W, Feng Q, Mu Y, Liu L, Xu C, Zhao J. Susceptibility-guided sequential strategy versus empirical therapy for Helicobacter pylori infection: study protocol for a randomised controlled trial. Trials 2023; 24:413. [PMID: 37337241 DOI: 10.1186/s13063-023-07457-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2023] [Accepted: 06/13/2023] [Indexed: 06/21/2023] Open
Abstract
BACKGROUND New treatment strategies are required against infections caused by Helicobacter pylori, which grows increasingly resistant to antibiotics. Polymerase chain reaction-based methods for antibiotic susceptibility testing are available for detecting H. pylori-specific mutations that confer resistance to clarithromycin and levofloxacin. Several meta-analyses have compared eradication rates for susceptibility-guided versus empirical therapy for H. pylori treatment; however, all have significant limitations and high heterogeneity, and the results are contradictory. The main objective of this trial is to assess whether a sequential strategy based on molecular susceptibility testing-guided therapy for H. pylori has a better eradication rate than empirical therapy. METHODS This trial is designed as a prospective, randomised, open-label, active-controlled and single-centre study. Men and women who are H. pylori-positive, naïve to treatment, and aged 18-65 years will be recruited. A total of 500 participants will be randomised to receive either empirical therapy or a susceptibility-guided sequential strategy. Bismuth quadruple therapy will be the empirical first-line therapy, and in case of failure, high-dose dual (proton-pump inhibitor + amoxicillin) treatment will be the rescue therapy. For the susceptibility-guided sequential strategy, regimen selection will be based on H. pylori susceptibility to clarithromycin (first-line) and levofloxacin (rescue). A first-line treatment of clarithromycin triple therapy will be selected for clarithromycin-sensitive strains. For clarithromycin resistance, a high-dose dual therapy will be selected. During the rescue treatment, a levofloxacin quadruple regimen will be selected for levofloxacin-sensitive strains, and a furazolidone quadruple regimen will be selected for others. The primary outcome is the first-line eradication rate in both groups, and the overall (including first and rescue therapies) H. pylori eradication rate in both groups is one of the secondary outcomes. The eradication rates of H. pylori will be analysed by intention-to-treat analysis, modified intention-to-treat analysis, and per-protocol analysis. DISCUSSION This randomised controlled trial will provide objective and valid evidence about the value of polymerase chain reaction-based molecular methods for antibiotic susceptibility testing in guiding H. pylori eradication. TRIAL REGISTRATION Clinicaltrials.gov NCT05549115. Released on 18 September 2022. First posted on 22 September 2022. Enrolment of the first participant on 20 September 2022. The study is retrospectively registered.
Collapse
Affiliation(s)
- Kemei Lu
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China
| | - Cuicui Lang
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China
| | - Xuefei Zou
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China
| | - Lina Zang
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China
| | - WeiWei Sang
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China
| | - Qian Feng
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China
| | - Ying Mu
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China
| | - Lifeng Liu
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China
| | - Chunhong Xu
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China
| | - Jingrun Zhao
- Department of Gastroenterology, Liaocheng People's Hospital, No. 67 DongchangXi Road, Liaocheng, Shandong Province, China.
| |
Collapse
|
6
|
Guo SH, Liu YM, Wang ZY, Wang FF, Mao YK, Hu YW, Han P, Cuthbertson AGS, Qiu BL, Sang W. Transcriptome analysis reveals TOR signalling-mediated plant flush shoots governing Diaphorina citri Kuwayama oviposition. Insect Mol Biol 2021; 30:264-276. [PMID: 33410566 DOI: 10.1111/imb.12693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/06/2020] [Revised: 12/31/2020] [Accepted: 01/04/2021] [Indexed: 06/12/2023]
Abstract
Asian Citrus Psyllid (ACP), Diaphorina citri, is a key vector transmitting the causative agent of Huanglongbing (HLB) disease. Population growth of ACP is evident after feeding on plant flush shoots, as they only oviposit here. However, the underlying mechanism as to why flush shoots govern oviposition is unclear. This study compares the fecundity and ovarian morphology of ACP between young flush and mature leaves. Furthermore, the transcriptome of mated females infesting Murraya paniculata was analysed. Finally, the gene of the key Target of Rapamycin (TOR) signalling pathway was silenced by RNAi. Results indicated that flush shoot feeding activated the development of the psyllids ovary and therefore induced oviposition. A total of 126 and 2794 differentially expressed genes were detected at 1 and 5 days, respectively, after pest infestation of flush shoots compared to mature leaves. Many genes are involved in protein metabolism, Mitogen-Activated Protein Kinase (MAPK) signalling pathway, hormone synthesis, and TOR signalling pathway: all thought to activate reproduction. Silencing of the positive regulator gene DcRheb in the TOR pathway resulted in lower levels of ecdysone and juvenile hormone and decreased vitellogenin synthesis, further disrupting reproductive ability. This study enhances understanding of the molecular mechanism underlying ACP's reproductive strategy.
Collapse
Affiliation(s)
- S-H Guo
- Key Laboratory of Bio-Pesticide Creation and Application, South China Agricultural University, Guangzhou, China
| | - Y-M Liu
- Key Laboratory of Bio-Pesticide Creation and Application, South China Agricultural University, Guangzhou, China
| | - Z-Y Wang
- Key Laboratory of Bio-Pesticide Creation and Application, South China Agricultural University, Guangzhou, China
| | - F-F Wang
- Key Laboratory of Bio-Pesticide Creation and Application, South China Agricultural University, Guangzhou, China
| | - Y-K Mao
- Guangdong Provincial Bioengineering Institute (Guangzhou Sugarcane Industry Research Institute), Guangzhou, China
| | - Y-W Hu
- Guangdong Provincial Bioengineering Institute (Guangzhou Sugarcane Industry Research Institute), Guangzhou, China
| | - P Han
- CAS Key Laboratory of Biogeography and Bioresource in Arid Land, Chinese Academy of Sciences, Ürümqi, China
| | | | - B-L Qiu
- Key Laboratory of Bio-Pesticide Creation and Application, South China Agricultural University, Guangzhou, China
| | - W Sang
- Key Laboratory of Bio-Pesticide Creation and Application, South China Agricultural University, Guangzhou, China
| |
Collapse
|
7
|
Hu S, Shu H, Yuan J, Gao J, Mu P, Ren C, Sang W, Guo L, Chen H. Characterisation of Wheat–Oat Flour Extrudate: Physicochemical and Β-Glucan Attributes. AAlim 2020. [DOI: 10.1556/066.2020.49.4.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The objective of this study was to evaluate the effect of wheat–oat flour ratio on the physical properties and β-glucan characteristics of extrudates. Results showed that increasing the wheat–oat flour ratio resulted in a decrease in the water solubility index (r2=0.8567) and hardness (r2=0.9316), whereas the expansion ratio (r2=0.9307) and water absorption index (r2=0.9061) increased. Wheat flour generally caused an increase in L values from 57.81 to 62.94 providing bright samples. Few cells were observed at high wheat–oat flour ratios under a scanning electron microscope, and a smooth surface was noted. Meanwhile, the total (r2=0.9867) and soluble (r2=0.9848) β-glucan contents were inversely proportional to the wheat–oat flour ratio. Extrudates with added wheat flour had a high molecular weight, but wheat flour had no significant (P<0.05) effect on the viscosity of β-glucan extracts. Conclusively, incorporation of wheat flour at a wheat–oat flour ratio of 2.33 provides ready-to-eat food based on whole oat flour, on account of improving the texture and providing sufficient β-glucan contents (0.806 g/100 g) without significantly affecting β-glucan viscosity.
Collapse
Affiliation(s)
- S. Hu
- aState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi. China
- bSino-German Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi. China
- cSchool of Food Science and Technology, Nanchang University, Nanchang 330031, Jiangxi. China
| | - H. Shu
- aState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi. China
- bSino-German Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi. China
- cSchool of Food Science and Technology, Nanchang University, Nanchang 330031, Jiangxi. China
| | - J.L. Yuan
- aState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi. China
- dSchool of Pharmaceutical Science, Nanchang University, Nanchang 330006, Jiangxi. China
| | - J.Y. Gao
- aState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi. China
- cSchool of Food Science and Technology, Nanchang University, Nanchang 330031, Jiangxi. China
| | - P.Y. Mu
- eInstitute of Crop Research, Xinjiang Academy of Agricultural and Reclamation Sciences, Shihezi 832000, Xinjiang. China
| | - C.Z. Ren
- fBaicheng Academy of Agricultural Sciences, Baicheng 137000, Jilin. China
| | - W. Sang
- eInstitute of Crop Research, Xinjiang Academy of Agricultural and Reclamation Sciences, Shihezi 832000, Xinjiang. China
| | - L.C. Guo
- fBaicheng Academy of Agricultural Sciences, Baicheng 137000, Jilin. China
| | - H.B. Chen
- aState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi. China
- bSino-German Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi. China
| |
Collapse
|
8
|
Yang JJ, Sang W, Xu KL. [Research progress of CAR-T cell therapy for relapsed/refractory diffuse large B-cell lymphoma]. Zhonghua Nei Ke Za Zhi 2019; 58:849-852. [PMID: 31665867 DOI: 10.3760/cma.j.issn.0578-1426.2019.11.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- J J Yang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | | | | |
Collapse
|
9
|
Wan YK, Sang W, Chen B, Yang YG, Zhang LQ, Sun AN, Liu YJ, Xu Y, Cai YP, Wang CB, Shen YF, Jiang YW, Zhang XY, Xu W, Hong M, Chen T, Xu RR, Li F, Xu YL, Xue Y, Lu YL, He ZM, Dong WM, Chen Z, Ji MH, Yang YY, Zhai LJ, Zhao Y, Wu GQ, Ding JH, Cheng J, Cai WB, Sun YM, Ouyang J. [Distribution and drug resistance of pathogens at hematology department of Jiangsu Province from 2014 to 2015: results from a multicenter, retrospective study]. Zhonghua Xue Ye Xue Za Zhi 2017; 38:602-606. [PMID: 28810329 PMCID: PMC7342276 DOI: 10.3760/cma.j.issn.0253-2727.2017.07.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Subscribe] [Scholar Register] [Received: 11/12/2016] [Indexed: 11/05/2022]
Abstract
Objective: To describe the distribution and drug resistance of pathogens at hematology department of Jiangsu Province from 2014 to 2015 to provide reference for empirical anti-infection treatment. Methods: Pathogens were from hematology department of 26 tertiary hospitals in Jiangsu Province from 2014 to 2015. Antimicrobial susceptibility testing was carried out according to a unified protocol using Kirby-Bauer method or agar dilution method. Collection of drug susceptibility results and corresponding patient data were analyzed. Results: The separated pathogens amounted to 4 306. Gram-negative bacteria accounted for 64.26%, while the proportions of gram-positive bacteria and funguses were 26.99% and 8.75% respectively. Common gram-negative bacteria were Escherichia coli (20.48%) , Klebsiella pneumonia (15.40%) , Pseudomonas aeruginosa (8.50%) , Acinetobacter baumannii (5.04%) and Stenotropho-monas maltophilia (3.41%) respectively. CRE amounted to 123 (6.68%) . Common gram-positive bacteria were Staphylococcus aureus (4.92%) , Staphylococcus hominis (4.88%) and Staphylococcus epidermidis (4.71%) respectively. Candida albicans were the main fungus which accounted for 5.43%. The rates of Escherichia coli and Klebsiella pneumonia resistant to carbapenems were 3.5%-6.1% and 5.0%-6.3% respectively. The rates of Pseudomonas aeruginosa resistant to tobramycin and amikacin were 3.2% and 3.3% respectively. The resistant rates of Acinetobacter baumannii towards tobramycin and cefoperazone/sulbactam were both 19.2%. The rates of Stenotrophomonas maltophilia resistant to minocycline and sulfamethoxazole were 3.5% and 9.3% respectively. The rates of Staphylococcus aureus, Enterococcus faecium and Enterococcus faecalis resistant wards vancomycin were 0, 6.4% and 1.4% respectively; also, the rates of them resistant to linezolid were 1.2%, 0 and 1.6% respectively; in addition, the rates of them resistant to teicoplanin were 2.8%, 14.3% and 8.0% respectively. Furthermore, MRSA accounted for 39.15% (83/212) . Conclusions: Pathogens were mainly gram-negative bacteria. CRE accounted for 6.68%. The rates of Escherichia coli and Klebsiella pneumonia resistant to carbapenems were lower compared with other antibacterial agents. The rates of gram-positive bacteria resistant to vancomycin, linezolid and teicoplanin were still low. MRSA accounted for 39.15%.
Collapse
Affiliation(s)
- Y K Wan
- The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - J Ouyang
- The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| |
Collapse
|
10
|
Wang X, Zhang L, Sun A, Yang X, Sang W, Jiang Y, Cheng J, Wang J, Zhou M, Chen B, Ouyang J. Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology. Eur J Clin Microbiol Infect Dis 2017; 36:1073-1081. [DOI: 10.1007/s10096-016-2895-2] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2016] [Accepted: 12/14/2016] [Indexed: 12/14/2022]
|
11
|
Bi B, Xiao X, Zhang H, Gao J, Tao M, Niu H, Wang Y, Wang Q, Chen C, Sun N, Li K, Fu J, Gan Z, Sang W, Zhang G, Yang L, Tian T, Li Q, Yang Q, Sun L, Li Y, Rong H, Guan C, Zhao X, Ye D, Zhang Y, Ma Z, Li H, He K, Chen J, Cai Y, Zhou C, Luo Y, Wang S, Gao S, Liu J, Guo L, Guan J, Kang Z, Di D, Li Y, Shi S, Li Y, Chen Y, Flint J, Kendler K, Liu Y. A comparison of the clinical characteristics of women with recurrent major depression with and without suicidal symptomatology. Psychol Med 2012; 42:2591-2598. [PMID: 22716960 PMCID: PMC3488812 DOI: 10.1017/s003329171200058x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/20/2011] [Revised: 03/02/2012] [Accepted: 03/06/2012] [Indexed: 11/22/2022]
Abstract
BACKGROUND The relationship between recurrent major depression (MD) in women and suicidality is complex. We investigated the extent to which patients who suffered with various forms of suicidal symptomatology can be distinguished from those subjects without such symptoms. METHOD We examined the clinical features of the worst episode in 1970 Han Chinese women with recurrent DSM-IV MD between the ages of 30 and 60 years from across China. Student's t tests, and logistic and multiple logistic regression models were used to determine the association between suicidality and other clinical features of MD. RESULTS Suicidal symptomatology is significantly associated with a more severe form of MD, as indexed by both the number of episodes and number of MD symptoms. Patients reporting suicidal thoughts, plans or attempts experienced a significantly greater number of stressful life events. The depressive symptom most strongly associated with lifetime suicide attempt was feelings of worthlessness (odds ratio 4.25, 95% confidence interval 2.9-6.3). Excessive guilt, diminished concentration and impaired decision-making were also significantly associated with a suicide attempt. CONCLUSIONS This study contributes to the existing literature on risk factors for suicidal symptomatology in depressed women. Identifying specific depressive symptoms and co-morbid psychiatric disorders may help improve the clinical assessment of suicide risk in depressed patients. These findings could be helpful in identifying those who need more intense treatment strategies in order to prevent suicide.
Collapse
Affiliation(s)
- B. Bi
- The First Hospital of China Medical University, Shenyang, People's Republic of China (PRC)
| | - X. Xiao
- The First Hospital of China Medical University, Shenyang, People's Republic of China (PRC)
| | - H. Zhang
- The First Hospital of China Medical University, Shenyang, People's Republic of China (PRC)
| | - J. Gao
- ZheJiang Traditional Chinese Medical Hospital, Hangzhou, PRC
| | - M. Tao
- Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, PRC
| | - H. Niu
- No. 1 Hospital of Zhengzhou University, Zhengzhou, PRC
| | - Y. Wang
- Shandong Mental Health Center, Shan Dong, PRC
| | - Q. Wang
- Beijing Anding Hospital, Capital Medical University, Beijing, PRC
| | - C. Chen
- No. 1 Hospital of Medical College of Xian Jiaotong University, Xian, Shaan Xi, PRC
| | - N. Sun
- No. 1 Hospital of Shanxi Medical University, Shanxi, PRC
| | - K. Li
- Mental Hospital of Jiangxi Province, Jiangxi, PRC
| | - J. Fu
- ShengJing Hospital of China Medical University, Liaoning, PRC
| | - Z. Gan
- No. 3 Affiliated Hospital of Zhongshan University, Guangdong, PRC
| | - W. Sang
- Hebei Mental Health Center, Hebei, PRC
| | - G. Zhang
- No. 4 Affiliated Hospital of Jiangsu University, Jiang Su, PRC
| | - L. Yang
- Jilin Brain Hospital, Jilin, PRC
| | - T. Tian
- Tianjin Anding Hospital, Tianjin, PRC
| | - Q. Li
- No. 1 Mental Health Center Affiliated Harbin Medical University, Heilongjiang, PRC
| | - Q. Yang
- Chongqing Mental Health Center, Chongqing, PRC
| | - L. Sun
- Psychiatric Hospital of Henan Province, Henan, PRC
| | - Ying Li
- Dalian No. 7 People's Hospital and Dalian Mental Health Center, Dalian, PRC
| | - H. Rong
- Shenzhen Kangning Hospital, Shenzhen, PRC
| | - C. Guan
- Nanjing Brain Hospital, Jiang Su, PRC
| | - X. Zhao
- The First Hospital of Hebei Medical University, Shijiazhuang, PRC
| | - D. Ye
- Sichuan Mental Health Center, Sichuan, PRC
| | - Y. Zhang
- Lanzhou University Second Hospital, Second Clinical Medical College of Lanzhou University, Gansu Province, PRC
| | - Z. Ma
- No. 1 Hospital of Chongqing Medical University, Chongqing, PRC
| | - H. Li
- Mental Health Center of West China Hospital of Sichuan University, Si Chuan, PRC
| | - K. He
- Shanghai Tongji University Affiliated Tongji Hospital, Shanghai, PRC
| | - J. Chen
- Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Mental Health Center, Shanghai, PRC
| | - Y. Cai
- Fudan University Affiliated Huashan Hospital, Shanghai, PRC
| | - C. Zhou
- Wuhan Mental Health Center, Hubei, PRC
| | - Y. Luo
- No. 3 Hospital of Heilongjiang Province, Heilongjiang, PRC
| | - S. Wang
- The First Affiliated Hospital of Jinan University, Guangzhou, PRC
| | - S. Gao
- Ningbo Kangning Hospital, Zhejiang, PRC
| | - J. Liu
- Suzhou Guangji Hospital, Jiangsu, PRC
| | - L. Guo
- The Fourth Military Medical University Affiliated Xijing Hospital, Shaanxi, PRC
| | - J. Guan
- Guangzhou Brain Hospital/Guangzhou Psychiatric Hospital, Guangzhou, PRC
| | - Z. Kang
- No. 4 People's Hospital of Liaocheng, Shandong, PRC
| | - D. Di
- Mental Health Institute of Jining Medical College, Shandong, PRC
| | - Yajuan Li
- Xian Mental Health Center, Xian, Shanxi, PRC
| | - S. Shi
- Fudan University Affiliated Huashan Hospital, Shanghai, PRC
| | - Yihan Li
- Wellcome Trust Centre for Human Genetics, Oxford, UK
| | - Y. Chen
- Clinical Trial Service Unit, Richard Doll Building, Oxford, UK
| | - J. Flint
- Wellcome Trust Centre for Human Genetics, Oxford, UK
| | - K. Kendler
- Virginia Commonwealth University (VCU), Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Richmond, VA, USA
| | - Y. Liu
- The First Hospital of China Medical University, Shenyang, People's Republic of China (PRC)
| |
Collapse
|
12
|
Cong E, Li Y, Shao C, Chen J, Wu W, Shang X, Wang Z, Liu Y, Liu L, Gao C, Li Y, Wu J, Deng H, Liu J, Sang W, Liu G, Rong H, Gan Z, Li L, Li K, Pan J, Li Y, Cui Y, Sun L, Liu L, Liu H, Zhao X, Zhang Y, Zhang R, Chen Y, Wang X, Li H, Chen Y, Lin Y, Kendler KS, Flint J, Shi S. Childhood sexual abuse and the risk for recurrent major depression in Chinese women. Psychol Med 2012; 42:409-417. [PMID: 21835095 PMCID: PMC3250087 DOI: 10.1017/s0033291711001462] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/02/2011] [Revised: 07/06/2011] [Accepted: 07/06/2011] [Indexed: 02/05/2023]
Abstract
BACKGROUND Studies in Western countries have repeatedly shown that women with a history of childhood sexual abuse (CSA) are at increased risk for developing major depression (MD). Would this relationship be found in China? METHOD Three levels of CSA (non-genital, genital, and intercourse) were assessed by self-report in two groups of Han Chinese women: 1970 clinically ascertained with recurrent MD and 2597 matched controls. Diagnostic and other risk factor information was assessed at personal interview. Odds ratios (ORs) were calculated by logistic regression and regression coefficients by linear or Poisson regression. RESULTS Any form of CSA was significantly associated with recurrent MD [OR 3.26, 95% confidence interval (CI) 1.95-5.45]. This association strengthened with increasing CSA severity: non-genital (OR 2.47, 95% CI 1.17-5.23), genital (OR 2.77, 95% CI 1.32-5.83) and intercourse (OR 13.35, 95% CI 1.83-97.42). The association between any form of CSA and MD remained significant after accounting for parental history of depression, childhood emotional neglect (CEN), childhood physical abuse (CPA) and parent-child relationship. Among the depressed women, those with CSA had an earlier age of onset, longer depressive episodes and an increased risk for generalized anxiety disorder (GAD; OR 1.92, 95% CI 1.39-2.66) and dysthymia (OR 2.16, 95% CI 1.52-3.09). CONCLUSIONS In Chinese women CSA is strongly associated with MD and this association increases with greater severity of CSA. Depressed women with CSA have an earlier age of onset, longer depressive episodes and increased co-morbidity with GAD and dysthymia. Although reporting biases cannot be ruled out, our results are consistent with the hypothesis that, as in Western countries, CSA substantially increases the risk for MD in China.
Collapse
Affiliation(s)
- E. Cong
- Huashan Hospital, Fudan University, Shanghai, P.R. China
- Wellcome Trust Centre for Human Genetics, Oxford, UK
| | - Y. Li
- Wellcome Trust Centre for Human Genetics, Oxford, UK
| | - C. Shao
- Huashan Hospital, Fudan University, Shanghai, P.R. China
| | - J. Chen
- Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China
| | - W. Wu
- Tongji Hospital, Shanghai Tongji University, Shanghai, P.R. China
| | - X. Shang
- Nanjing Brain Hospital, Nanjing, Jiangsu, P.R. China
| | - Z. Wang
- No. 4 Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, P.R. China
| | - Y. Liu
- Tianjin Anding Hospital, Hexi District, Tianjin, P.R. China
| | - L. Liu
- Shandong Mental Health Centre, Jinan, Shandong, P.R. China
| | - C. Gao
- No. 1 Hospital of Medical College of Xian Jiaotong University, Xi'an, Shaanxi, P.R. China
| | - Y. Li
- No. 1 Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China
| | - J. Wu
- No. 1 Mental Health Centre Affiliated Harbin Medical University, Nangang District, Harbin, Heilongjiang, P.R. China
| | - H. Deng
- Mental Health Centre of West China Hospital of Sichuan University, Wu Hou District, Chengdu, Sichuan, P.R. China
| | - J. Liu
- Beijing Anding Hospital, Capital Medical University, Xicheng District, Beijing, P.R. China
| | - W. Sang
- Hebei Mental Health Centre, Baoding, Hebei, P.R. China
| | - G. Liu
- Shengjing Hospital of China Medical University, Heping District Shenyang, Liaoning, P.R. China
| | - H. Rong
- Shenzhen Kangning Hospital, Luo Hu, Shenzhen, Guangdong, P.R. China
| | - Z. Gan
- No. 3 Affiliated Hospital of Sun Yat-sen University, Tian He District, Guangzhou, Guangdong, P.R. China
| | - L. Li
- No. 1 Hospital of Shanxi Medical University, Taiyuan, Shanxi, P.R. China
| | - K. Li
- Mental Hospital of Jiangxi Province, Nanchang, Jiangxi, P.R. China
| | - J. Pan
- The First Affiliated Hospital of Jinan University, Tian He District, Guangzhou, Guangdong, P.R. China
| | - Y. Li
- Wuhan Mental Health Centre, Wuhan, P.R. China
| | - Y. Cui
- No. 3 Hospital of Heilongjiang Province, Beian, Heilongjiang, P.R. China
| | - L. Sun
- Jilin Brain Hospital, Siping, Jilin, P.R. China
| | - L. Liu
- The First Hospital of China Medical University, He Ping District, Shenyang, Liaoning, P.R. China
| | - H. Liu
- Dalian No. 7 People's Hospital and Dalian Mental Health Centre, Gan Jing Zi District, Dalian, Liaoning, P.R. China
| | - X. Zhao
- The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China
| | - Y. Zhang
- Lanzhou University Second Hospital, Second Clinical Medical College of Lanzhou University, Lanzhou, Gansu Province, P.R. China
| | - R. Zhang
- Psychiatric Hospital of Henan Province, Xinxiang, Henan, P.R. China
| | - Y. Chen
- The Fourth Military Medical University affiliated Xijing Hospital, Xi'an, Shaanxi, P.R. China
| | - X. Wang
- No. 4 People's Hospital of Liaocheng, Liaocheng, Shandong, P.R. China
| | - H. Li
- Guangzhou Brain Hospital/Guangzhou Psychiatric Hospital, Li Wan District, Guangzhou, Guangdong, P.R. China
| | - Y. Chen
- Clinical Trial Service Unit, Richard Doll Building, Oxford, UK
| | - Y. Lin
- Fuzhou Neuropsychiatric Hospital, Fuzhou City, Fujian, P.R. China
| | - K. S. Kendler
- Department of Psychiatry, Virginia Commonwealth University, Virginia Institute for Psychiatric and Behavioral Genetics, Richmond, VA, USA
| | - J. Flint
- Wellcome Trust Centre for Human Genetics, Oxford, UK
| | - S. Shi
- Huashan Hospital, Fudan University, Shanghai, P.R. China
- Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China
| |
Collapse
|
13
|
Schmarr HG, Sang W, Ganß S, Koschinski S, Meusinger R. New insights into the synthesis and characterization of 2-methoxy-3-alkylpyrazines and their deuterated isotopologues. J Labelled Comp Radiopharm 2011. [DOI: 10.1002/jlcr.1888] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
14
|
Zhu X, Dong B, Sang W, Kong F, Wang L. [Aluminum toxicity and tolerance in wheat]. Huan Jing Ke Xue 2001; 22:33-6. [PMID: 11569110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
The physiological and biochemical effects of different species of aluminum on the wheat Al-tolerant TAM202 and Al-sensitive TAM105 were investigated. The results showed that mononuclear Al could be absorbed by both of the two strains. Compared with TAM105, however, TAM202 absorbed less aluminum. The pH of the nutrient solution rose with the hydroponics of the two-cultivars. The content of proline in leaves of TAM105 increased obviously. The contents of protein, hexose and uronic acid in cell wall of TAM202 were higher than that in TAM105 under 75 mumol.L-1 Al. The results indicated that Al can activated the synthesis of some components relative to Al-tolerance in cell wall.
Collapse
Affiliation(s)
- X Zhu
- State Key Lab. of Pollution Control and Resources Reuse, School of the Environment, Nanjing University, Nanjing 210093, China
| | | | | | | | | |
Collapse
|
15
|
Sang W. Taking your proposals straight to the people. Health Soc Serv J 1979; 89:1078-9. [PMID: 10244178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
Abstract
The saga of the secure units at Prestwich Hospital, Manchester, goes on. A new chapter is added as author recounts the role the local community played (and continues to play) in a development that has had more than its fair share of local and national limelight.
Collapse
|
16
|
Sang W. The scales of justice. Health Soc Serv J 1977; 87:1701. [PMID: 10306243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|